31804-36-1

Basic information

• Product Name: 1-BROMO-3-METHOXY-2-METHYLBENZENE
• Synonyms: 1-BROMO-3-METHOXY-2-METHYLBENZENE;3-Bromo-2-methylanisole
• CAS NO: 31804-36-1
• Molecular Formula: C₈H₉BrO
• Molecular Weight: 201.07
• Mol File: 31804-36-1.mol
• Article Data: 13

Chemical Properties

• Melting Point: 150-151 °C
• Boiling Point: 217°C at 760 mmHg
• Flash Point: 99.3°C
• Appearance: /
• Density: 1.378g/cm³
• Vapor Pressure: 0.199mmHg at 25°C
• Refractive Index: 1.535
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-BROMO-3-METHOXY-2-METHYLBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BROMO-3-METHOXY-2-METHYLBENZENE(31804-36-1)
• EPA Substance Registry System: 1-BROMO-3-METHOXY-2-METHYLBENZENE(31804-36-1)

Safety Data

• Hazardous Substances Data: 31804-36-1(Hazardous Substances Data)

Usage

General Description

1-Bromo-3-methoxy-2-methylbenzene, also known as o-bromoanisole or 3-bromoanisole, is an organic compound with the formula C8H9BrO. 1-BROMO-3-METHOXY-2-METHYLBENZENE belongs to the family of bromobenzenes, and specifically can be classified as a bromoanisole. It is a light yellow to amber liquid and has a molecular weight of 201.06 g/mol. It is typically used in laboratory settings for organic synthesis. Like all bromobenzenes, 1-Bromo-3-methoxy-2-methylbenzene is relatively nonpolar and thus insoluble in water but soluble in organic solvents. The handling and storage of this chemical should be done with caution as it can be harmful if swallowed, inhaled, or comes in contact with skin. It plays a significant role in the manufacturing of dyes, pharmaceuticals, and other organic compounds.

InChI:InChI=1/C8H9BrO/c1-6-7(9)4-3-5-8(6)10-2/h3-5H,1-2H3

Upstream product

• 7766-23-6 3-bromo-2-methylphenol 
• 77-78-1 dimethyl sulfate 
• 19500-02-8 2-methyl-3-methoxyaniline 
• 74-88-4 methyl iodide 
• 4837-88-1 6-methoxy-2-nitrotoluene 
• 55289-35-5 2-bromo-6-nitrotoluene 
• 55289-36-6 3-bromo-2-methylaniline 

Downstream Products

• 573693-08-0 2-bromo-4-methoxy-3-methyl-phenylamine 
• 573693-12-6 3-(2-bromo-4-methoxy-3-methyl-phenylamino)-4-methoxy-benzoic acid methyl ester 
• 573693-14-8 8-bromo-1,6-bis-(tert-butyl-diphenyl-silanyloxy)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 573693-16-0 [1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hex-1-enyl)-7-methyl-9H-carbazol-4-yl]-methanol 
• 573693-15-9 1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hex-1-enyl)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 573693-11-5 2-bromo-4-methoxy-3-methyl-1-nitro-benzene 
• 868694-07-9 5-bromo-2-(3-methoxy-2-methylbenzoyl)-benzoic acid 
• 868694-08-0 4-bromo-2-(3-methoxy-2-methylbenzoyl)-benzoic acid 
• 1313617-76-3 (3-methoxy-2-methylphenyl)boronic acid 

Relevant articles and documents

-

-

Total Synthesis of (Nor)illudalane Sesquiterpenes Based on a C(sp3)-H Activation Strategy

Three (nor)illudalane sesquiterpenes were synthesized from a common intermediate in racemic and enantioenriched forms using Pd0-catalyzed C(sp3)-H arylation as a key step. The configuration of the isolated, highly symmetric quaternar

Propionic Acid Derivatives and Methods of Use Thereof

Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5 and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.